Dr. Davor Nestić
Ruđer Bošković Institute
Bijenička 54
HR-10000 Zagreb
Publications
Journal articles
Scientific and review papers
-
Bates, E., Davies, J., Vanova, J., Nestić, D., Meniel, V., Koushyar, S., Cunliffe, T., Mundy, R., Moses, E., Uusi-Kerttula, H., Baker, A., Cole, D., Majhen, D., Rizkallah, P., Phesse, T., Chester, J. & Parker, A. (2022) Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10. Molecular Therapy - Oncolytics, 25, 43-56 doi:10.1016/j.omto.2022.03.007.
doiwww.sciencedirect.comdoi.orgfulir.irb.hr -
Nestić, D., Božinović, K., Drašković, I., Kovačević, A., van den Bosch, J., Knežević, J., Custers, J., Ambriović- Ristov, A. & Majhen, D. (2022) Human adenovirus type 26 induced IL-6 gene expression in an αvβ3 integrin- and NF-κB-dependent manner. Viruses-Basel, 14 (4), 672, 16 doi:10.3390/v14040672.
doiwww.mdpi.comfulir.irb.hr -
Nestić, D., Hozić, A., Brkljača, Z., Butorac, A., Pažur, K., Jullienne, B., Cindrić, M., Ambriović-Ristov, A., Benihoud, K. & Majhen, D. (2021) Integrin αvβ3 and disulfide bonds play important roles in NGR-retargeted adenovirus transduction efficiency. Life sciences, 291, 120116, 9 doi:10.1016/j.lfs.2021.120116.
doi -
Tadijan, A., Humphries, J., Samaržija, I., Stojanović, N., Zha, J., Čuljak, K., Tomić, M., Paradžik, M., Nestić, D., Kang, H., Humphries, M. & Ambriović-Ristov, A. (2021) The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin α6β4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity. Frontiers in cell and developmental biology, 9, 786758, 17 doi:10.3389/fcell.2021.786758.
doiwww.frontiersin.orgdoi.orgfulir.irb.hr -
Nestić, D., Božinović, K., Pehar, I., Wallace, R., Parker, A. & Majhen, D. (2021) The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal. Pharmaceutics, 13 (10), 1585, 18 doi:10.3390/pharmaceutics13101585.
doiwww.mdpi.comdoi.orgfulir.irb.hr -
Božinović, K., Nestić, D., Gradišar Centa, U., Ambriović-Ristov, A., Dekanić, A., de Bisschop, L., Remškar, M. & Majhen, D. (2020) In-vitro toxicity of molybdenum trioxide nanoparticles on human keratinocytes. Toxicology, 444, 152564, 11 doi:10.1016/j.tox.2020.152564.
doi -
Hulin-Curtis, S., Davies, J., Nestić, D., Bates, E., Baker, A., Cunliffe, T., Majhen, D., Chester, J. & Parker, A. (2020) Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications. Cancer gene therapy, 27, 785-798 doi:10.1038/s41417-019-0156-0.
doidoi.orgwww.nature.com -
Paradžik, M., Humphries, J., Stojanović, N., Nestić, D., Majhen, D., Dekanić, A., Samaržija, I., Sedda, D., Weber, I., Humphries, M. & Ambriović-Ristov, A. (2020) KANK2 links αVβ5 focal adhesions to microtubules and regulates sensitivity to microtubule poisons and cell migration. Frontiers in cell and developmental biology, 8, 125, 17 doi:10.3389/fcell.2020.00125.
doidoi.orgwww.frontiersin.orgfulir.irb.hr -
Nestić, D., Uil, T., Ma, J., Roy, S., Vellinga, J., Baker, A., Custers, J. & Majhen, D. (2019) αvβ3 Integrin is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26. Journal of virology, 93 (1), e01474, 18 doi:10.1128/JVI.01474-18.
doi